Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ADRAUOTCMKTS:CBBTOTCMKTS:CTAMOTCMKTS:EQUR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADRAUAdara Acquisition$0.02$0.02$0.02▼$11.20N/AN/A1,795 shsN/ACBBTCerebain Biotech$0.00$0.00$0.00▼$0.47N/AN/A11.21 million shs2.04 million shsCTAMA.M. Castle & Co.$0.01$0.01$0.01▼$0.01N/AN/A100 shs1 shsEQURADB International Group$0.00$0.00$0.00▼$0.05N/AN/AN/AN/AA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADRAUAdara Acquisition0.00%0.00%0.00%0.00%0.00%CBBTCerebain Biotech0.00%0.00%0.00%0.00%0.00%CTAMA.M. Castle & Co.0.00%0.00%0.00%0.00%0.00%EQURADB International Group0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationADRAUAdara AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ACBBTCerebain BiotechN/AN/AN/AN/AN/AN/AN/AN/ACTAMA.M. Castle & Co.N/AN/AN/AN/AN/AN/AN/AN/AEQURADB International GroupN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADRAUAdara Acquisition 0.00N/AN/AN/ACBBTCerebain Biotech 0.00N/AN/AN/ACTAMA.M. Castle & Co. 0.00N/AN/AN/AEQURADB International Group 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADRAUAdara AcquisitionN/AN/AN/AN/AN/AN/ACBBTCerebain BiotechN/AN/AN/AN/AN/AN/ACTAMA.M. Castle & Co.N/AN/AN/AN/AN/AN/AEQURADB International GroupN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADRAUAdara AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/ACBBTCerebain BiotechN/AN/A0.00∞N/AN/AN/AN/AN/ACTAMA.M. Castle & Co.N/AN/A0.00∞N/AN/AN/AN/AN/AEQURADB International GroupN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthADRAUAdara AcquisitionN/AN/AN/AN/AN/ACBBTCerebain BiotechN/AN/AN/AN/AN/ACTAMA.M. Castle & Co.N/AN/AN/AN/AN/AEQURADB International GroupN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADRAUAdara AcquisitionN/ACBBTCerebain BiotechN/ACTAMA.M. Castle & Co.N/AEQURADB International GroupN/AInsider OwnershipCompanyInsider OwnershipADRAUAdara AcquisitionN/ACBBTCerebain BiotechN/ACTAMA.M. Castle & Co.N/AEQURADB International Group79.63%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADRAUAdara Acquisition847N/AN/ANot OptionableCBBTCerebain Biotech2N/AN/ANot OptionableCTAMA.M. Castle & Co.11,000N/AN/ANot OptionableEQURADB International Group1N/AN/ANot OptionableCBBT, CTAM, ADRAU, and EQUR HeadlinesRecent News About These CompaniesNBC files FCC 'equal time' notice after Kamala Harris appears on 'SNL'November 12, 2024 | usatoday.comLilly Ledbetter, equal pay and women's rights activist, dies at 86November 3, 2024 | nbcnews.comUCLA Must Ensure Equal Campus Access to Jewish Students, Judge RulesAugust 16, 2024 | wsj.comJudge tells UCLA it must protect Jewish students' equal access on campusAugust 1, 2024 | usatoday.comGovt provides equal development opportunities to youth: PMJuly 20, 2024 | radio.gov.pkREqual Rights AmendmentMay 13, 2024 | si.eduSAn Equal Start?May 1, 2024 | cambridge.orgCTurkish Cypriot leader stresses equal international status to restart negotiations with southMarch 18, 2024 | aa.com.trAOffice of Equal Employment and Supplier DiversityFebruary 27, 2024 | si.eduSLabour’s equal pay plan for ethnic minorities is all stakeholder, and no substanceFebruary 9, 2024 | ft.comSusan B. Anthony and the Struggle for Equal RightsFebruary 4, 2024 | cambridge.orgCEqual=Grounds Coffee is getting new ownershipDecember 24, 2023 | whec.comWEqual Employment OpportunitiesDecember 19, 2023 | smith.eduSIs equal pay actually possible?December 8, 2023 | bbc.comBEqual Is Not FairDecember 5, 2023 | nasdaq.comThe future is equalNovember 21, 2023 | oxfamamerica.orgOGovt committed to provide equal development opportunities to all citizens: PM KakarNovember 10, 2023 | radio.gov.pkRAll Inverters Are (Not) Created EqualNovember 6, 2023 | hackaday.comHLatinas need to work until they're 90 to earn what white men make by age 60October 7, 2023 | msnbc.comMStrikes: Health workers call for equal treatment over paySeptember 29, 2023 | bbc.co.ukNew MarketBeat Followers Over TimeCBBT, CTAM, ADRAU, and EQUR Company DescriptionsAdara Acquisition OTCMKTS:ADRAU$0.02 0.00 (0.00%) As of 03/17/2023Adara Acquisition Corp. was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination target in any industry, it currently intends to concentrate its search for a target business operating in the consumer products and related industries.Cerebain Biotech OTCMKTS:CBBT$0.0009 0.00 (0.00%) As of 09/2/2021Cerebain Biotech Corp. is a biomedical company, which engages in the creation and clinical development of a minimally invasive implantable device. It focuses on the discovery of products for the treatment of Alzheimer's disease utilizing Omentum. The company was founded on December 18, 2007 and is headquartered in Costa Mesa, CA.A.M. Castle & Co. OTCMKTS:CTAM$0.01 0.00 (0.00%) As of 05/11/2023A.M. Castle & Co. engages in the distribution of specialty metals and supply chain services. The firm serves the producer equipment, commercial and military aircraft, heavy equipment, industrial goods, and construction equipment sectors. Its products include alloy and stainless steels, nickel alloys, aluminum, titanium, and carbon. The company was founded in 1890 and is headquartered in Oak Brook, IL.ADB International Group OTCMKTS:EQUR$0.0002 0.00 (0.00%) As of 10/5/2023E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CoreWeave's $9 Billion Power Play for Core Scientific Micron Insiders Sell But Investors Should Buy, Buy, Buy Could Dutch Bros Dethrone Starbucks? Why Investors Are Perking Up ExxonMobil: Limited Risk and Lots of Reward With This Oil Play D-Wave Is Rising Again Despite Dilution—What’s the Deal? Datadog Joins S&P 500, Triggering a New Wave of Upside MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
